Publication | Open Access

Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial

Health SciencesAntimicrobial StewardshipAntibioticsPhase 2BPediatric Intensive CareSepsisPharmacotherapyNon-inferiority TrialAntimicrobial PharmacokineticsAntimicrobial ChemotherapyMedicineClinical MicrobiologyGram-positive SepsisDrug Resistance